$LAB
STANDARD BIOTOOLS INC. Stock $lab

$lab Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000116219414000016 Filed on May 12, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q1
Revenue	$27.61M	$25.72M	$14.54M
YoY Change	57.93%	76.98%	32.8%
Cost Of Revenue	$9.955M	$8.704M	$4.259M
YoY Change	104.16%	104.37%	20.11%
Gross Profit	$17.65M	$17.02M	$10.28M
YoY Change	40.05%	65.63%	38.88%
Gross Profit Margin	63.94%	66.16%	70.7%
Selling, General & Admin	$18.66M	$15.26M	$11.15M
YoY Change	60.86%	36.88%	18.54%
% of Gross Profit	105.68%	89.64%	108.47%
Research & Development	$11.37M	$7.646M	$4.197M
YoY Change	127.62%	82.18%	-1.92%
% of Gross Profit	64.43%	44.92%	40.84%
Depreciation & Amortization	$3.720M	$2.320M	$580.0K
YoY Change	509.84%	300.0%	16.0%
% of Gross Profit	21.07%	13.63%	5.64%
Operating Expenses	$30.03M	$22.90M	$15.34M
YoY Change	80.96%	49.27%	12.14%
Operating Profit	-$12.38M	-$16.58M	-$5.067M
YoY Change	210.2%	227.2%	-19.35%
Interest Expense	$1.415M	$1.026M	$10.00K
YoY Change	70650.0%	10160.0%	-96.74%
% of Operating Profit
Other Income/Expense, Net	-$18.00K	$48.00K	-$213.0K
YoY Change	-53.85%	-122.54%	249.18%
Pretax Income	-$13.81M	-$17.56M	-$3.513M
YoY Change	242.59%	399.77%	-47.18%
Income Tax	-$1.128M	-$2.143M	$38.00K
% Of Pretax Income
Net Earnings	-$12.68M	-$15.41M	-$3.551M
YoY Change	213.45%	334.07%	-46.92%
Net Earnings / Revenue	-45.94%	-59.92%	-24.43%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.45	-$0.57	-$0.14
COMMON SHARES
Basic Shares Outstanding	28.06M shares	27.87M shares	25.27M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$94.70M	$143.1M	$79.60M
YoY Change	56.79%	79.77%	104.63%
Cash & Equivalents	$43.68M	$101.0M	$61.82M
Short-Term Investments	$51.10M	$42.10M	$17.80M
Other Short-Term Assets	$3.000M	$3.500M	$1.600M
YoY Change	50.0%	118.75%	0.0%
Inventory	$16.36M	$13.43M	$7.371M
Prepaid Expenses
Receivables	$13.33M	$18.79M	$10.06M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$127.4M	$178.8M	$98.56M
YoY Change	58.22%	81.43%	73.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.57M	$9.377M	$5.019M
YoY Change	135.17%	86.83%	39.42%
Goodwill	$104.2M	$104.2M
YoY Change
Intangibles	$107.8M	$110.6M
YoY Change
Long-Term Investments	$62.30M	$15.10M	$7.300M
YoY Change	169.7%	106.85%	19.67%
Other Assets	$4.405M	$6.558M	$2.363M
YoY Change	28.39%	177.53%	-46.3%
Total Long-Term Assets	$290.3M	$245.9M	$14.68M
YoY Change	823.88%	1575.14%	4.86%
TOTAL ASSETS
Total Short-Term Assets	$127.4M	$178.8M	$98.56M
Total Long-Term Assets	$290.3M	$245.9M	$14.68M
Total Assets	$417.7M	$424.7M	$113.2M
YoY Change	273.1%	275.07%	60.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.637M	$8.001M	$3.214M
YoY Change	282.42%	148.94%	-21.61%
Accrued Expenses	$8.296M	$8.206M	$4.149M
YoY Change	78.75%	97.78%	-28.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$27.31M	$25.74M	$11.54M
YoY Change	134.87%	123.07%	-34.82%
LONG-TERM LIABILITIES
Long-Term Debt	$195.3M	$195.2M	$0.00
YoY Change
Other Long-Term Liabilities	$1.140M	$888.0K	$205.0K
YoY Change	267.74%	333.17%	-79.5%
Total Long-Term Liabilities	$1.140M	$888.0K	$205.0K
YoY Change	267.74%	333.17%	-79.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.31M	$25.74M	$11.54M
Total Long-Term Liabilities	$1.140M	$888.0K	$205.0K
Total Liabilities	$255.9M	$257.3M	$13.11M
YoY Change	1784.54%	1862.11%	-30.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$285.4M	-$272.8M	-$244.4M
YoY Change	14.9%	11.62%
Common Stock	$28.00K	$28.00K	$25.00K
YoY Change	12.0%	12.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$161.8M	$167.4M	$100.1M
YoY Change
Total Liabilities & Shareholders Equity	$417.7M	$424.7M	$113.2M
YoY Change	273.1%	275.07%	60.17%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	-$12.68M	-$15.41M	-$3.551M
YoY Change	213.45%	334.07%	-46.92%
Depreciation, Depletion And Amortization	$3.720M	$2.320M	$580.0K
YoY Change	509.84%	300.0%	16.0%
Cash From Operating Activities	$310.0K	-$10.55M	-$884.0K
YoY Change	-111.74%	1093.1%	-86.69%
INVESTING ACTIVITIES
Capital Expenditures	$2.750M	$1.813M	$698.0K
YoY Change	102.21%	159.74%	75.82%
Acquisitions		$113.2M	$0.00
YoY Change
Other Investing Activities	-$56.10M	-$119.4M	$3.090M
YoY Change	114.53%	-3964.72%	-37.83%
Cash From Investing Activities	-$58.86M	-$121.2M	$2.395M
YoY Change	113.88%	-5161.84%	-47.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$0.00
YoY Change			-100.0%
Cash From Financing Activities	1.170M	$197.5M	$1.767M
YoY Change	80.0%	11077.08%	-158.16%
NET CHANGE
Cash From Operating Activities	310.0K	-$10.55M	-$884.0K
Cash From Investing Activities	-58.86M	-$121.2M	$2.395M
Cash From Financing Activities	1.170M	$197.5M	$1.767M
Net Change In Cash	-57.38M	$65.72M	$3.278M
YoY Change	94.44%	1904.91%	-164.14%
FREE CASH FLOW
Cash From Operating Activities	$310.0K	-$10.55M	-$884.0K
Capital Expenditures	$2.750M	$1.813M	$698.0K
Free Cash Flow	-$2.440M	-$12.36M	-$1.582M
YoY Change	-39.0%	681.29%	-77.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	8001000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4353000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18790000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10552000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5392000	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8206000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-730000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-757000	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	440921000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	354465000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1300000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3400000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	USD
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	54000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	USD
CY2013Q4	us-gaap	Assets Assets	116915000	USD
CY2014Q1	us-gaap	Assets Assets	424723000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	104584000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	178813000	USD
CY2013Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	68572000	USD
CY2014Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	134743000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	42100000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	101024000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61815000	USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58649000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	65763000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3166000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-18986000	USD
CY2014Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	29509000	USD
CY2013Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2014Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	10696000	USD
CY2014Q1	us-gaap	Cash Cash	23534000	USD
CY2013Q4	us-gaap	Cash Cash	17714000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35261000	USD
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28016000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25811000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25811000	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28016000	shares
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	28000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	26000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15442000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3555000	USD
CY2014Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	195249000	USD
CY2013Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2014Q1	us-gaap	Cost Method Investments Realized Gain Loss CostMethodInvestmentsRealizedGainLoss	0	USD
CY2013Q1	us-gaap	Cost Method Investments Realized Gain Loss CostMethodInvestmentsRealizedGainLoss	1777000	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4259000	USD
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	8704000	USD
CY2013Q1	us-gaap	Costs And Expenses CostsAndExpenses	19602000	USD
CY2014Q1	us-gaap	Costs And Expenses CostsAndExpenses	42303000	USD
CY2014Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.005
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5331000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2721000	USD
CY2014Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3711000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1899000	USD
CY2014Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	920000	USD
CY2013Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	584000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.57
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-112000	USD
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	42000	USD
CY2014Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4198000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5485000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	57400000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8400000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	11200000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	11200000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	11200000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	11200000	USD
CY2014Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	110600000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	0	USD
CY2014Q1	us-gaap	Goodwill Goodwill	104245000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17557000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3513000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2143000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1128000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2514000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	601000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2933000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-866000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1415000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	439000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2511000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-13000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3103000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	246000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1554000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	435000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	410000	USD
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	110600000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	10000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	1026000	USD
CY2014Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6059000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3871000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	8148000	USD
CY2014Q1	us-gaap	Inventory Net InventoryNet	13426000	USD
CY2014Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5467000	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2650000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1627000	USD
CY2014Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1900000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	44000	USD
CY2014Q1	us-gaap	Liabilities Liabilities	257292000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	20501000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	424723000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	116915000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17951000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	25736000	USD
CY2014Q1	us-gaap	Licenses Revenue LicensesRevenue	112000	USD
CY2013Q1	us-gaap	Licenses Revenue LicensesRevenue	116000	USD
CY2014Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0375
CY2014Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	10000000.0	USD
CY2013Q4	us-gaap	Long Term Investments LongTermInvestments	1942000	USD
CY2014Q1	us-gaap	Long Term Investments LongTermInvestments	15130000	USD
CY2014Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	77490000	USD
CY2013Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	17547000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	197499000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1767000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2395000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121231000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10547000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-884000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-3551000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-15414000	USD
CY2014Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16579000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5067000	USD
CY2014Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	716000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6558000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3571000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-28000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	651000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	888000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-213000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	48000	USD
CY2013Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2014Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	113190000	USD
CY2013Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	7414000	USD
CY2014Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	15003000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1813000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	698000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3450000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1540000	USD
CY2014Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash provided by financing activities, or change in cash and cash equivalents. </font></div></div>
CY2014Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	195212000	USD
CY2013Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2014Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	8775000	USD
CY2013Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	7390000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	0	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	3117000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1767000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2287000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9377000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6818000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4197000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7646000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-272761000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-257347000	USD
CY2014Q1	us-gaap	Revenue From Grants RevenueFromGrants	163000	USD
CY2013Q1	us-gaap	Revenue From Grants RevenueFromGrants	165000	USD
CY2013Q1	us-gaap	Revenues Revenues	14535000	USD
CY2014Q1	us-gaap	Revenues Revenues	25724000	USD
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	25449000	USD
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	14254000	USD
CY2013Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	0	USD
CY2014Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2648000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1255000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15257000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11146000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3379000	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	49083000	USD
CY2014Q1	us-gaap	Short Term Investments ShortTermInvestments	42123000	USD
CY2014Q1	fldm	Business Acquisitionintangibleassetsanddevelopedtechnologydeferredtaxliabilitiesfrom Canadaand Californianetofamortization BusinessAcquisitionintangibleassetsanddevelopedtechnologydeferredtaxliabilitiesfromCanadaandCalifornianetofamortization	31708000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	96414000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	167431000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26900000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	25242000	shares
CY2013Q4	fldm	Business Acquisitionintangibleassetsanddevelopedtechnologydeferredtaxliabilitiesfrom Canadaand Californianetofamortization BusinessAcquisitionintangibleassetsanddevelopedtechnologydeferredtaxliabilitiesfromCanadaandCalifornianetofamortization	0	USD
CY2014Q1	fldm	Business Combination Fair Valueof Inventory BusinessCombinationFairValueofInventory	517000	USD
CY2013Q1	fldm	Business Combination Fair Valueof Inventory BusinessCombinationFairValueofInventory	0	USD
CY2014Q1	fldm	Date Of Reincorporation Of Company DateOfReincorporationOfCompany	2007-07
CY2014Q1	fldm	Issuanceof Common Stockand Options Acquisitions IssuanceofCommonStockandOptionsAcquisitions	78196000	USD
CY2013Q1	fldm	Issuanceof Common Stockand Options Acquisitions IssuanceofCommonStockandOptionsAcquisitions	0	USD
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001162194
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28060958	shares
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1999-05-11
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	FLUIDIGM CORP
CY2014Q1	dei	Trading Symbol TradingSymbol	FLDM

Files In Submission

Name	View Source	Status
0001162194-14-000016-index-headers.html	Edgar Link	pending
0001162194-14-000016-index.html	Edgar Link	pending
0001162194-14-000016.txt	Edgar Link	pending
0001162194-14-000016-xbrl.zip	Edgar Link	pending
ex-102xletteragreementwith.htm	Edgar Link	pending
ex-103xlicenseagreementwit.htm	Edgar Link	pending
ex-104xdvssublicenseagreem.htm	Edgar Link	pending
ex-105xmodificationagreeme.htm	Edgar Link	pending
ex-311xq12014form10xq.htm	Edgar Link	pending
ex-312xq12014form10xq.htm	Edgar Link	pending
ex-321xq12014form10xq.htm	Edgar Link	pending
ex-322xq12014form10xq.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fldm-20140331.xml	Edgar Link	completed
fldm-20140331.xsd	Edgar Link	pending
fldm-20140331_cal.xml	Edgar Link	unprocessable
fldm-20140331_def.xml	Edgar Link	unprocessable
fldm-20140331_lab.xml	Edgar Link	unprocessable
fldm-20140331_pre.xml	Edgar Link	unprocessable
q12014form10-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LAB
STANDARD BIOTOOLS INC. Stock $lab

2014 Q2 Form 10-Q Financial Statement

#000116219414000016 Filed on May 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LAB STANDARD BIOTOOLS INC. Stock $lab

2014 Q2 Form 10-Q Financial Statement

#000116219414000016 Filed on May 12, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LAB
STANDARD BIOTOOLS INC. Stock $lab